drugset / Press release
Initial clinical results from OTC-HOPE, the first in vivo, liver directed, AAV-mediated gene insertion study in neonatal OTC deficiency: complete clinical response observed in first male infant to receive ECUR-506 and complete 24-week Phase 1/2 study
2025-05-14 · iECURE, Inc. · original iecure.com ↗
15th 3rd 97th 50th 85th Figure 11: Length-for-age Boys (Birth to 2 Y ears) 15th 3rd 97th 50th 85th
The release as fetched from its publisher. iecure.com ↗